IE36995B1 - Improvements in and relating to attenuated viruses - Google Patents

Improvements in and relating to attenuated viruses

Info

Publication number
IE36995B1
IE36995B1 IE1716/72A IE171672A IE36995B1 IE 36995 B1 IE36995 B1 IE 36995B1 IE 1716/72 A IE1716/72 A IE 1716/72A IE 171672 A IE171672 A IE 171672A IE 36995 B1 IE36995 B1 IE 36995B1
Authority
IE
Ireland
Prior art keywords
virus
attenuated
cattle
dec
diluent
Prior art date
Application number
IE1716/72A
Other languages
English (en)
Other versions
IE36995L (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IE36995L publication Critical patent/IE36995L/xx
Publication of IE36995B1 publication Critical patent/IE36995B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16732—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • C12N2710/16764—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IE1716/72A 1971-12-10 1972-12-08 Improvements in and relating to attenuated viruses IE36995B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2161344A DE2161344C3 (de) 1971-12-10 1971-12-10 Herstellung von Virusstämmen, welche die natürlichen Abwehrmechanismen eines Wirtsorganismus stimulieren, ohne dabei gleichzeitig antigen zu wirken und Arzneimittel zur Prophylaxe und Behandlung von viralen und bakteriellen Infektionen des Menschen und der Tiere, einen solchen Virusstamm enthaltend

Publications (2)

Publication Number Publication Date
IE36995L IE36995L (en) 1973-06-10
IE36995B1 true IE36995B1 (en) 1977-04-13

Family

ID=5827622

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1716/72A IE36995B1 (en) 1971-12-10 1972-12-08 Improvements in and relating to attenuated viruses

Country Status (22)

Country Link
JP (2) JPS5924137B2 (enExample)
AR (1) AR204075A1 (enExample)
AT (1) AT326817B (enExample)
AU (1) AU473209B2 (enExample)
BE (1) BE792484A (enExample)
BG (1) BG21417A3 (enExample)
CA (1) CA988848A (enExample)
CH (1) CH577558A5 (enExample)
CS (1) CS189587B2 (enExample)
DD (1) DD108115A5 (enExample)
DE (1) DE2161344C3 (enExample)
DK (1) DK143201C (enExample)
ES (1) ES409464A1 (enExample)
FR (1) FR2162637B1 (enExample)
GB (1) GB1356076A (enExample)
HU (1) HU167086B (enExample)
IE (1) IE36995B1 (enExample)
NL (1) NL178014C (enExample)
PH (1) PH12597A (enExample)
SE (1) SE8400283L (enExample)
SU (1) SU439956A3 (enExample)
ZA (1) ZA728709B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0063657A1 (en) * 1981-04-29 1982-11-03 Merck & Co. Inc. Topical application of interferon inducers

Also Published As

Publication number Publication date
ZA728709B (en) 1973-08-29
DK143201C (da) 1981-12-14
NL178014C (nl) 1986-01-02
DD108115A5 (enExample) 1974-09-05
PH12597A (en) 1979-06-27
JPS6011013B2 (ja) 1985-03-22
BG21417A3 (bg) 1976-05-20
DK143201B (da) 1981-07-20
FR2162637B1 (enExample) 1976-07-02
DE2161344B2 (de) 1980-05-08
ES409464A1 (es) 1976-03-16
CA988848A (en) 1976-05-11
SE8400283D0 (sv) 1984-01-20
CS189587B2 (en) 1979-04-30
FR2162637A1 (enExample) 1973-07-20
JPS4862919A (enExample) 1973-09-01
DE2161344C3 (de) 1986-10-02
NL178014B (nl) 1985-08-01
IE36995L (en) 1973-06-10
JPS4862912A (enExample) 1973-09-01
GB1356076A (en) 1974-06-12
CH577558A5 (enExample) 1976-07-15
SU439956A3 (ru) 1974-08-15
JPS5924137B2 (ja) 1984-06-07
NL7216628A (enExample) 1973-06-13
AU473209B2 (en) 1976-06-17
SE8400283L (sv) 1984-01-20
AT326817B (de) 1975-12-29
AR204075A1 (es) 1975-11-20
DE2161344A1 (de) 1973-06-20
ATA1041972A (de) 1975-03-15
AU4992072A (en) 1974-06-13
BE792484A (fr) 1973-06-08
HU167086B (enExample) 1975-08-28

Similar Documents

Publication Publication Date Title
Levy-Koenig et al. Immunology of Interferons: II. Heterospecific Activities of Human Interferons and Their Neutralization by Antibody
GB697619A (en) Reducing attack by combustion products
IE36995B1 (en) Improvements in and relating to attenuated viruses
GB1169930A (en) Improvements in or relating to Lactam Salts
ES336902A1 (es) Procedimiento para la elaboracion de glicoles que estan im-purificados por productos de oxidacion.
GB1444968A (en) Manufacture of t-butanol
ES436028A1 (es) Un procedimiento de atenuacion del virus de la rinotraquei- tis viral felina virulenta.
USD134664S (en) Combination bottle cap opener and bricklayer s line pin
USD206914S (en) Vacuum bottle jacket
Suemasa et al. A Study on the Fatigue of Housewives (Part 6)
FR1503745A (fr) Dispositif d'aspiration, d'épuration et d'évacuation des produits de combustion
USD220869S (en) Bottle
USD207191S (en) Display stand for jars or the like
GB1413401A (en) Influenza vaccine
FR914535A (fr) Procédé de préparation des interpolymères d'éthylène avec les esters vinyliques et produits en résultant
USD227656S (en) Combined bottle and cap
USD201260S (en) Figure
USD137526S (en) Combined can and bottle opener
FR1203719A (fr) Perfectionnements au procédé de préparation de l'alumine à partir de la bauxite et d'autres matières à base d'aluminium, par une attaque pyrogène effectuée dans des installations d'agglomération, soit sous aspiration, soit sous pression
GB1444980A (en) Psychotropic medicinal preparation
USD201051S (en) -figure
USD134181S (en) Design for a bottle or similar article
USD201582S (en) Figure
GB659864A (en) A method of purifying di-ammonium phosphate
TAHAMA Studies on the dwarf disease of mulberry tree (X) Further experiments on the transmission by leafhopper, Hishimonus disciguttus Walker.-1